Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
Chem Biodivers
; 18(11): e2100361, 2021 Nov.
Article
in En
| MEDLINE
| ID: mdl-34547176
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acetylcholinesterase
/
Butyrylcholinesterase
/
Cholinesterase Inhibitors
/
Neuroprotective Agents
/
Alzheimer Disease
/
Rivastigmine
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Chem Biodivers
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2021
Type:
Article
Affiliation country:
South Africa